This insurance stock is on an impressive run. How to ride the momentum with less risk

MetLife (MET) is well-positioned in the life insurance and benefits sector, exhibiting fundamental momentum that the broader market hasn’t fully priced in.

Backed by scale, brand equity, and an experienced leadership team, MetLife is firing on all cylinders.

Premium & Sales Growth: In Q1, MetLife’s core premiums and fees grew 10%, driven largely by international and domestic demand: Asia jumped 22%, Latin America 20%, while US Group Benefits gained 15%.Unlocking Efficiency via AI: While many investors focus on AI companies, they may be ignoring how AI and technological innovation can help old economy businesses. MetLife is poised to lead the industry in margin expansion (20–25 bps annually) by keeping expense growth firmly below revenue gains.Earnings Power: Consensus estimates project nearly 25% EPS growth over the next two years, from an expected $9.94 in FY2026 to $12.40 in FY2028. Roughly 5% of the forecast EPS growth is expected from buybacks (there is just under $1.2 billion remaining in the existing buyback program). Strong recent sales, favorable group life underwriting, and rising equity markets are boosting alternative investments. ROE and Capital Management: MetLife’s average ROE of 17.2% is at the upper end of its 15–17% target range. 

Given MetLife’s strong fundamental tailwinds and clear path to EPS upside, I like a September 77.5/87.5/92.5 call spread risk reversal (below), structured to either capture further upside, or potentially purchase the stock close to the long-term average ~$78.

It allows investors to capture MetLife’s upward momentum while mitigating immediate downside risk after the stock’s impressive recent rally and also reducing the impact of “theta” (aka “decay”).

Defined Risk, Leveraged Reward: By purchasing an at-the-money call, you gain exposure to MetLife’s upside. By simultaneously selling a higher-strike call and lower strike put, you collect premium that lowers your net cost (debit), reducing your breakeven.Mitigating Volatility: While rising equity markets and strong alternative investment returns provide a tailwind for MetLife’s stock, selling the outer strike helps offset the cost of implied volatility. Note, too, that September expiration captures earnings (the company is expected to report on August 6th) – after which options premiums tend to fall more sharply, a phenomenon sometimes referred to as a post-catalyst “vol crush”.EPS Timelines: Choosing the Sep expiration not only captures upcoming quarterly earnings reports, but acknowledges that the market has been choppier recently, and it captures most of September, which has also historically seen above-average volatility.

Trade Management: If MetLife’s stock surges, use the opportunity to “monetize” (i.e., cover) the short put, and possibly roll the debit call spread up (meaning to higher strikes), or up and out (in time).